ARCHIVES

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

This article is from The Cancer Letter archive.

Vol. 01 No. 05 | March 8, 1974

Download PDF Visit The Full Archive

Related Articles

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

ACS Announces New Awards for Nurses

October 30, 1987

Advisors Say 10 Percent Payline “Not Tenable;” All NCI Programs Must Share Budget Cuts.

March 31, 2006

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011